Equity
€2,113 from €492,466 in 2023
Equity fell by 100% in 2 years.
Stratospire
Lifetime
5 annual accounts with figures on one time axispeak €449,555 (2022)
€389,523▲ 120%
peak €340,836 (2022)
€288,113▲ 109%
peak €492,466 (2023)
€2,113▼ 98.5%
€301,340▲ 147%
Board2 names since 2021
2 directors and 1 other
Documentsfilings and deeds
23-08-202623 days late
2025micro format
Gross margin from €177,299 to €389,523Result from €137,989 to €288,113Appointment: (director) 14-02Dividend €425,988Equity from €139,989 to €2,113Debts from €121,996 to €301,340
Key points
from the 2025 annual accountsTurnover
≈ €590,000 estimated
The micro format states no turnover.
Debts
€301,340 99% of the balance sheet
Suppliers 1%Taxes and wages 23%Other 77%
Of this, €300,466 falls due within a year.
Liquidity
1.00 was 2.09 in 2024
Short-term debts rose from €121,935 to €300,466.
Filings
5 annual accounts 5 late
The 2021 accounts came latest: 36 days after the end of the period.
Position in the sector
0.7%
Lower solvency than 95% of companies in human health. Sector median 63.0% · 21,311 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 2,154 companies had the same profile as Stratospire has now. Each dot stands for 6 companies, two years later.
95.9%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,154 companies, not a prediction for Stratospire. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Appointment: (director)
“De uitoefening van de geneeskunde door de artsvennoot, richting anesthesie en intensieve geneeskunde. Dit…” (deed in Dutch) · General meeting of 11-02-2025 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0769578994
Registered office moved from Brussels to Schaerbeek
New registered office: Avenue Paul Deschanel 66 te 1030 Schaarbeek · Previous registered office: Léon Lepagestraat 3-1000 Brussel · General meeting of 14-10-2022 · Gazette deed
Incorporation
Founding capital of €2,000, 2,000 shares · Founder: · Appointment: (director) · published on 14-06-2021 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Stratospire Schaerbeek | €303,453 | €389,523 | 0.7% | - |
| MIGUEL CASSELMAN Denderleeuw | €291,537 | €389,254 | 7.0% | - |
| OLIVERI A. RADIOLOGIE Thuin | €293,713 | €365,587 | 3.0% | - |
| DOKTER SARAH ROELS Bruges | €295,255 | €400,961 | 1.0% | - |
| Dr. Maaike Rathé, N.K.O. Roeselare | €305,686 | €384,387 | 94.2% | - |
| Belent Tielt | €341,004 | €372,861 | 82.1% | - |
| HBSC Tienen | €293,439 | €371,415 | 1.0% | - |
These companies have the same main activity as Stratospire: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €292,000 and €341,000, founded between 2020 and 2022.
Official details
Source: KBO- Status
- Active since 10-06-2021Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.318.271.6901030 Schaerbeek, since 10-06-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 24-11-2023
Insights on Stratospire
Stratospire files the micro format. That format states no turnover. The gross margin rose from €54,885 in 2021 to €389,523 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Stratospire
- What is the company number of Stratospire?
- The company number of Stratospire is 0769.578.994. The VAT number is the same number with BE in front: BE 0769.578.994.
- Where is Stratospire based?
- The registered office is at Paul Deschanellaan 66, 1030 Schaerbeek.Company details
- What does Stratospire do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of Stratospire?
- Stratospire is a private limited company (BV).
- When was Stratospire founded?
- Stratospire was founded on 10-06-2021.
- Is Stratospire still active?
- Yes, Stratospire is an active enterprise in the KBO register.
- What is the turnover of Stratospire?
- The turnover in financial year 2025 is ≈ €590,000. This figure is estimated from the gross margin of €389,523 and 31 comparable companies (NACE 86220). It probably lies between €520,000 and €810,000.Financials
- Is Stratospire profitable?
- In financial year 2025, Stratospire made a profit of €288,113.
- Where can I find the annual accounts of Stratospire?
- Stratospire filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Stratospire due?
- Stratospire must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.